newsfilter
← Latest News
GlobeNewswire·

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to